These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine. Kilias D, Macrae FA, Sharpe K, Young GP. Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):819-24. PubMed ID: 9332765 [Abstract] [Full Text] [Related]
3. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans. Bostick RM, Fosdick L, Lillemoe TJ, Overn P, Wood JR, Grambsch P, Elmer P, Potter JD. Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067 [Abstract] [Full Text] [Related]
4. Epidemiological use of rectal proliferation measures. Baron JA, Wargovich MJ, Tosteson TD, Sandler R, Haile R, Summers R, van Stolk R, Rothstein R, Weiss J. Cancer Epidemiol Biomarkers Prev; 1995 Nov; 4(1):57-61. PubMed ID: 7894325 [Abstract] [Full Text] [Related]
5. Pan cycle expression of proliferating cell nuclear antigen in human colorectal cancer and its proliferative correlations. Sawtell RM, Rew DA, Stradling RN, Wilson GD. Cytometry; 1995 Sep 15; 22(3):190-9. PubMed ID: 8556950 [Abstract] [Full Text] [Related]
11. The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps. Alberts DS, Einspahr J, Ritenbaugh C, Aickin M, Rees-McGee S, Atwood J, Emerson S, Mason-Liddil N, Bettinger L, Patel J, Bellapravalu S, Ramanujam PS, Phelps J, Clark L. Cancer Epidemiol Biomarkers Prev; 1997 Mar 15; 6(3):161-9. PubMed ID: 9138658 [Abstract] [Full Text] [Related]
12. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67. Taftachi R, Ayhan A, Ekici S, Ergen A, Ozen H. BJU Int; 2005 Mar 15; 95(4):650-4. PubMed ID: 15705097 [Abstract] [Full Text] [Related]
14. Rectal mucosal proliferation, dietary factors, and the risk of colorectal adenomas. Keku TO, Galanko JA, Murray SC, Woosley JT, Sandler RS. Cancer Epidemiol Biomarkers Prev; 1998 Nov 15; 7(11):993-9. PubMed ID: 9829707 [Abstract] [Full Text] [Related]
15. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling. Zeymer U, Fishbein MC, Forrester JS, Cercek B. Am J Pathol; 1992 Sep 15; 141(3):685-90. PubMed ID: 1381560 [Abstract] [Full Text] [Related]
17. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer. Anti M, Marra G, Percesepe A, Armelao F, Gasbarrini G. J Cell Biochem Suppl; 1994 Sep 15; 19():68-75. PubMed ID: 7823608 [Abstract] [Full Text] [Related]
18. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression. Cher ML, Chew K, Rosenau W, Carroll PR. Prostate; 1995 Feb 15; 26(2):87-93. PubMed ID: 7855002 [Abstract] [Full Text] [Related]